Intuitive Surgical, Inc. $ISRG is Triodos Investment Management BV’s 10th Largest Position

Triodos Investment Management BV lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 90,187 shares of the medical equipment provider’s stock after selling 1,050 shares during the period. Intuitive Surgical makes up approximately 2.9% of Triodos Investment Management BV’s portfolio, making the stock its 10th largest position. Triodos Investment Management BV’s holdings in Intuitive Surgical were worth $40,330,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. SteelPeak Wealth LLC boosted its holdings in shares of Intuitive Surgical by 28.7% in the 3rd quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock valued at $18,781,000 after buying an additional 9,364 shares in the last quarter. Atlantic Union Bankshares Corp lifted its position in Intuitive Surgical by 19.3% in the third quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider’s stock valued at $10,179,000 after acquiring an additional 3,676 shares during the last quarter. Amalgamated Bank lifted its position in Intuitive Surgical by 2.2% in the second quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock valued at $44,311,000 after acquiring an additional 1,772 shares during the last quarter. Bessemer Group Inc. boosted its stake in Intuitive Surgical by 89.3% in the second quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock valued at $428,386,000 after acquiring an additional 371,806 shares in the last quarter. Finally, World Investment Advisors grew its holdings in shares of Intuitive Surgical by 238.3% during the third quarter. World Investment Advisors now owns 5,399 shares of the medical equipment provider’s stock worth $2,415,000 after purchasing an additional 3,803 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Intuitive Surgical news, SVP Mark Brosius sold 4,500 shares of the business’s stock in a transaction that occurred on Friday, December 12th. The stock was sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the transaction, the senior vice president owned 907 shares in the company, valued at approximately $496,455.52. The trade was a 83.23% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Gary S. Guthart sold 24,500 shares of the stock in a transaction that occurred on Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total value of $12,987,450.00. Following the transaction, the director directly owned 3,694 shares of the company’s stock, valued at approximately $1,958,189.40. This trade represents a 86.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 56,189 shares of company stock valued at $30,785,441. 0.70% of the stock is owned by insiders.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $504.05 on Friday. The business has a 50 day simple moving average of $535.88 and a 200-day simple moving average of $510.74. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $607.35. The stock has a market capitalization of $179.00 billion, a PE ratio of 63.88, a price-to-earnings-growth ratio of 3.90 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. Intuitive Surgical’s revenue was up 18.8% compared to the same quarter last year. During the same period in the previous year, the company posted $2.21 EPS. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on ISRG shares. HSBC upped their target price on Intuitive Surgical from $644.00 to $653.00 and gave the company a “buy” rating in a research report on Monday, January 26th. Citigroup reiterated a “neutral” rating and issued a $590.00 price objective (down previously from $635.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Barclays set a $712.00 target price on shares of Intuitive Surgical and gave the stock an “overweight” rating in a research report on Monday, January 26th. Zacks Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Thursday. Finally, Wells Fargo & Company increased their price target on shares of Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research note on Friday, December 12th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $617.23.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.